The French drugmaker was a powerhouse in cancer back in the day with chemotherapies like Taxotere (docetaxel) and Jevtana (cabazitaxel), but has been a latecomer both to the immuno-oncology ...
Studies in recent years have shown that many chemotherapy drugs can affect prostate cancer. Some, such as docetaxel (Taxotere®, Docefrez™) and cabazitaxel (Jevtana®, approved in 2010), have been shown ...
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a prescription drug that’s used to treat prostate cancer in certain situations. Pluvicto comes as a solution for injection or infusion ...